Carsten Linnemann

Author PubWeight™ 9.98^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.	Nat Med	2010	2.92
2	TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.	Oncoimmunology	2012	1.78
3	Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.	Proc Natl Acad Sci U S A	2008	1.77
4	Pairing of T-cell receptor chains via emulsion PCR.	Eur J Immunol	2013	1.12
5	Blockade of TGF-β signaling greatly enhances the efficacy of TCR gene therapy of cancer.	J Immunol	2013	0.89
6	HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.	J Immunol	2013	0.81
7	Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.	Purinergic Signal	2013	0.79
8	Corrigendum: High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma.	Nat Med	2016	0.75